As of today (2024-04-19), the Forward Annual Dividend Yield of Adaptive Biotechnologies is 0.00%.
As of today (2024-04-19), the Trailing Annual Dividend Yield of Adaptive Biotechnologies is 0.00%.
ADPT's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.59 * Ranked among companies with meaningful Forward Dividend Yield % only.
Adaptive Biotechnologies's Dividends per Share for the
three
months ended in Dec. 2023 was $0.00.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison
For the Biotechnology subindustry, Adaptive Biotechnologies's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adaptive Biotechnologies Forward Dividend Yield % Distribution
For the Biotechnology industry and Healthcare sector, Adaptive Biotechnologies's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Adaptive Biotechnologies's Forward Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Adaptive Biotechnologies Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Adaptive Biotechnologies's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Adaptive Biotechnologies (Adaptive Biotechnologies) Business Description
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease ("MRD") in patients with multiple myeloma ("MM"), B cell acute lymphoblastic leukemia ("ALL") and chronic lymphocytic leukemia ("CLL") and is also available as a CLIA-validated laboratory developed test ("LDT") for patients with other lymphoid cancers, including diffuse large B-cell lymphoma ("DLBCL").
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ADPT has been successfully added to your